AGEN Agenus Inc

Price (delayed)

$2.98

Market cap

$124.09M

P/E Ratio

1.8

Dividend/share

N/A

EPS

$1.66

Enterprise value

$393.56M

?
Relative Growth: Rel. Growth: 84
Relative Strength: Rel. Strength: 16
Relative Valuation: Rel. Valuation: 99
Relative Profitability: Rel. Profitability: 72

Agenus is a clinical-stage immuno-oncology company focused on the discovery and development of therapies that engage the body's immune system to fight cancer. The Company's vision is to expand the ...

Highlights
The quick ratio has soared by 188% from the previous quarter and by 156% YoY
AGEN's net income has soared by 134% YoY

Key stats

What are the main financial stats of AGEN

AGEN stock price

How has the Agenus stock price performed over time
Intraday
-8.31%
1 week
-4.18%
1 month
-16.76%
1 year
-42.02%
YTD
-5.1%
QTD
-10.78%

Financial performance

How have Agenus's revenue and profit performed over time
Revenue
$123.87M
Gross profit
$122.98M
Operating income
$7.81M
Net income
$64.61M
Gross margin
99.3%
Net margin
52.2%
AGEN's operating income has surged by 138% since the previous quarter and by 107% year-on-year
AGEN's operating margin has soared by 135% from the previous quarter and by 106% YoY
AGEN's net income has soared by 134% YoY
Agenus's net margin has surged by 127% YoY

Price vs fundamentals

How does AGEN's price correlate with its fundamentals

Growth

What is Agenus's growth rate over time

Valuation

What is Agenus stock price valuation
P/E
1.8
P/B
N/A
P/S
0.91
EV/EBIT
3.23
EV/EBITDA
3.05
EV/Sales
3.18
The EPS has surged by 119% year-on-year
AGEN's equity is up by 35% YoY and by 18% QoQ
The stock's price to sales (P/S) is 73% less than its 5-year quarterly average of 3.4 and 17% less than its last 4 quarters average of 1.1
Agenus's revenue has increased by 24% YoY and by 8% from the previous quarter

Efficiency

How efficient is Agenus business performance
Agenus's return on assets has surged by 139% YoY
The return on sales has surged by 103% since the previous quarter
Agenus's ROIC has increased by 30% from the previous quarter

Dividends

What is AGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AGEN.

Financial health

How did Agenus financials performed over time
AGEN's total assets is 55% lower than its total liabilities
The quick ratio has soared by 188% from the previous quarter and by 156% YoY
AGEN's total liabilities is down by 21% YoY and by 18% from the previous quarter
AGEN's equity is up by 35% YoY and by 18% QoQ
The debt to equity has declined by 12% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.